IMAC Holdings, Inc. (BACK)
USD 1.1
(-5.17%)
USD 1.1
(-5.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 4.15 Million USD | -29.61% |
| 2021 | 5.9 Million USD | -35.38% |
| 2020 | 9.13 Million USD | 9.02% |
| 2019 | 8.38 Million USD | 43.67% |
| 2018 | 5.83 Million USD | 667.78% |
| 2017 | 759.82 Thousand USD | 51.97% |
| 2016 | 500 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | 1.12 Million USD | -46.15% |
| 2023 Q4 | - USD | -100.0% |
| 2023 FY | - USD | -100.0% |
| 2023 Q1 | 2.37 Million USD | -42.88% |
| 2023 Q2 | 2.08 Million USD | -12.19% |
| 2022 Q2 | 4.97 Million USD | -7.53% |
| 2022 FY | 4.15 Million USD | -29.61% |
| 2022 Q3 | 4.64 Million USD | -6.63% |
| 2022 Q1 | 5.38 Million USD | -8.81% |
| 2022 Q4 | 4.15 Million USD | -10.6% |
| 2021 Q3 | 6.69 Million USD | -14.01% |
| 2021 FY | 5.9 Million USD | -35.38% |
| 2021 Q1 | 7.52 Million USD | -17.6% |
| 2021 Q4 | 5.9 Million USD | -11.85% |
| 2021 Q2 | 7.78 Million USD | 3.46% |
| 2020 Q4 | 9.13 Million USD | -3.17% |
| 2020 Q2 | 10.32 Million USD | 11.18% |
| 2020 Q1 | 9.28 Million USD | 10.78% |
| 2020 FY | 9.13 Million USD | 9.02% |
| 2020 Q3 | 9.43 Million USD | -8.58% |
| 2019 Q3 | 9.03 Million USD | 6.82% |
| 2019 Q4 | 8.38 Million USD | -7.22% |
| 2019 Q2 | 8.45 Million USD | 2.88% |
| 2019 Q1 | 8.22 Million USD | 40.92% |
| 2019 FY | 8.38 Million USD | 43.67% |
| 2018 Q2 | 4.76 Million USD | 58.58% |
| 2018 FY | 5.83 Million USD | 667.78% |
| 2018 Q4 | 5.83 Million USD | 10.0% |
| 2018 Q3 | 5.3 Million USD | 11.24% |
| 2018 Q1 | 3 Million USD | 295.68% |
| 2017 Q4 | 759.82 Thousand USD | 0.0% |
| 2017 FY | 759.82 Thousand USD | 51.97% |
| 2016 FY | 500 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 100.0% |
| Addus HomeCare Corporation | 175.18 Million USD | 100.0% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | 100.0% |
| Amedisys, Inc. | 487.21 Million USD | 100.0% |
| American Oncology Network, Inc. | 128.32 Million USD | 100.0% |
| Astrana Health, Inc. | 321.01 Million USD | 100.0% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 100.0% |
| biote Corp. | 114.87 Million USD | 100.0% |
| Cryo-Cell International, Inc. | 10.89 Million USD | 100.0% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | 100.0% |
| COMPASS Pathways plc | 33.04 Million USD | 100.0% |
| DocGo Inc. | 46.49 Million USD | 100.0% |
| The Ensign Group, Inc. | 1.87 Billion USD | 100.0% |
| Healthcare Services Group, Inc. | 43.63 Million USD | 100.0% |
| InnovAge Holding Corp. | 113.03 Million USD | 100.0% |
| Assure Holdings Corp. | 14.8 Million USD | 100.0% |
| The Joint Corp. | 16.73 Million USD | 100.0% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 100.0% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | 100.0% |
| ModivCare Inc. | 1.14 Billion USD | 100.0% |
| NewGenIvf Group Limited | 332.55 Thousand USD | 100.0% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | 100.0% |
| Option Care Health, Inc. | 1.16 Billion USD | 100.0% |
| P3 Health Partners Inc. | 124.64 Million USD | 100.0% |
| P3 Health Partners Inc. | 124.64 Million USD | 100.0% |
| The Pennant Group, Inc. | 329.63 Million USD | 100.0% |
| Surgery Partners, Inc. | 3.06 Billion USD | 100.0% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | 100.0% |
| Talkspace, Inc. | - USD | NaN% |
| Talkspace, Inc. | - USD | NaN% |
| The Oncology Institute, Inc. | 119.81 Million USD | 100.0% |
| The Oncology Institute, Inc. | 119.81 Million USD | 100.0% |